Just released,GlaxoSmithKline:Can Supply 13.5M Japan Patients...

Just released,

GlaxoSmithKline:Can Supply 13.5M Japan Patients With Flu Drug
TOKYO (Dow Jones)--GlaxoSmithKline PLC's (GSK) Japanese subsidiary said Friday it is able to supply the Relenza influenza drug for 13.5 million people in Japan this season through March.

GlaxoSmithKline K.K. said in a statement it will consider increasing the planned supply of Relenza if needed.

Roche Holding AG's Japanese unit, Chugai Pharmaceutical Co. Ltd., said earlier in the week it plans a new seasonal supply of Tamiflu influenza drug for 12 million people.

Meanwhile, Japan's Ministry of Health, Labour and Welfare declined to comment on a reported plan to import vaccines effective against the swine flu virus from GlaxoSmithKline and Novartis AG.

A ministry official said the government will not disclose details about any specific contracts with pharmaceutical companies.

---------------
http://online.wsj.com/article/BT-CO-20090911-701596.html